Investing in the research powering breakthroughs in medicine

3 Views
Published
QQQ ETF featured holding Moderna is working to build new blood vessels in patients’ hearts after a heart attack. They’re leveraging their same mRNA technology that powers the COVID-19 vaccine.

Learn more about companies in the QQQ holdings directly from the agents of innovation driving their purpose. In this series, we learn how these innovators push the boundaries of what's possible to change lives and reshape reality.

Subscribe to Invesco US: https://www.youtube.com/c/Invesco?sub_confirmation=1
Watch more of Invesco US: https://www.youtube.com/c/Invesco

Invesco on Social LinkedIn: https://www.linkedin.com/company/invesco-us
Twitter: https://twitter.com/InvescoUS
Facebook: https://www.facebook.com/InvescoUS
Instagram: https://www.instagram.com/invescous/

About Invesco QQQ
Invesco QQQ is an exchange-traded fund that tracks the Nasdaq-100 Index™. The Index includes the 100 largest non-financial companies listed on the Nasdaq based on market cap.
About Invesco
Invesco is an independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. We have Specialized investment teams managing investments across a comprehensive range of asset classes, investment styles and geographies.

#InnovationRealized #InvescoQQQ #AgentsOfInnovation

Disclosure
This content should not be construed as an endorsement for or a recommendation to invest in Moderna. Moderna is not affiliated with Invesco.

QQQ Top 10 Holdings. Holdings are subject to change and are not buy/sell recommendations

Please read risks and other important information at https://www.invesco.com/us/qqq-etf/
Please read QQQ prospectus at https://connect.rightprospectus.com/Invesco/TADF/46090E103/P?site=ETF
Category
Management
Be the first to comment